Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2387-2021Class II

Merge Hemo, Software packages 10.2, 10.3, and 10.4

Merge Healthcare Incorporated / initiated 2021-07-23 / Terminated / root cause: software

Merge Healthcare, Inc. began a recall of Merge Hemo, Software packages 10.2, 10.3, and 10.4 on . FDA classified it as Class II and gives the reason as "The firm identified a safety issue affecting the software associated with Merge Hemo versions 9.x and 10.x, used in combination with an HL7 lab interface". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-2387-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Merge Healthcare Incorporated
Product
Merge Hemo, Software packages 10.2, 10.3, and 10.4
Product code
DQK Computer, Diagnostic, Programmable
Reason for recall
The firm identified a safety issue affecting the software associated with Merge Hemo versions 9.x and 10.x, used in combination with an HL7 lab interface.
Root cause tag
software
FDA root cause
Under Investigation by firm
Action
The firm issued an Urgent Field Safety Notice by email on 07/23/2021. The letter explained the issue and provided a workaround for the safe, continued use of the instrument until a software correction can be made.
Quantity in commerce
326 units
Distribution
US distribution
Product codes and lots
Version 10.2, UDI (01)00842000100430(10)10.2(11)190612 Version 10.3, UDI (01)00842000100874(10)10.3(11)200330 Version 10.4, UDI (01)00842000100966(10)10.4(11)210428

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2387-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2387-2021Class IITerminatedVoluntary: Firm initiated